Physician profile
Shaul Fishman
NPI 1306846621
$2,579.80
in general payments reported to CMS, 2019-2025
17 companies · $354 in 2025
The $354 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $954 · 2020: $123 · 2021: $84.50 · 2022: $404 · 2023: $310 · 2024: $349 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.34 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $676.85 | 2019-2025 | Lokelma |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $302.38 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $263.08 | 2022 | |
| Pfizer INC. | $260.18 | 2019-2025 | |
| Scpharmaceuticals INC. | $152.12 | 2023 | |
| Glaxosmithkline, LLC. | $122.21 | 2019 | |
| Genzyme Corporation | $121.63 | 2019 | |
| Optinose US, INC. | $120.87 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $113.63 | 2019 | |
| Irhythm Technologies, INC. | $103.36 | 2024 | Zio Monitor, Zio Xt Patch |
| Actelion Pharmaceuticals US, INC. | $94.08 | 2023 | Uptravi, Opsumit |
| Boston Scientific Corporation | $80.63 | 2022 | |
| Neurocrine Biosciences, INC. | $63.91 | 2024-2025 | Ingrezza |
| Medtronic, INC. | $41.52 | 2023 | Azure Xt Dr Mri Surescan |
| Amgen INC. | $24.12 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $19.98 | 2022 | |
| Chiesi USA, INC. | $19.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaul Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.